In the News
Advocacy is an activity by an individual or group which aims to influence decisions within political, economic, and social systems and institutions.
WHAT WE ARE WORKING ON
Our Latest News: Read about
our work in action.
Public Voices Rise
The Cancer Alliance represented by SECTION27 returned to court today in the matter of Cancer Alliance v the MEC for Health, Gauteng and 10 others. Today’s proceedings concerned an application for leave to appeal instituted by the provincial health respondents in the matter after a judgment...
Celgene Flagged
For overpricing bone marrow cancer drug The Competition Commission has referred for prosecution to the Competition Tribunal (“Tribunal”), international drug manufacturer Celgene Corporation (“Celgene Corp”) and its subsidiary Celgene Logistics S.a.r.l (“Celgene Logistics”) (collectively,...
Cancer Alliance Tackles Price Gouging
Represented by SECTION27, takes on multinational company Cancer Alliance tackles price gouging 14 November 2024, Johannesburg - The Cancer Alliance, represented by SECTION27, has been admitted...
Lenalidomide Price Case Progress
Access to Medicine: Lenalidomide Cancer Alliance submitted a case for the investigation of excessive pricing for lenalidomide to the South African Competition Commission in January 2023. The CompCom confirmed their intention to investigate this case in February 2023. Appendix A, 2024-02-06, Tbls...
Sa’s Medicine Patent Laws Must Be Changed
– INTERVIEW SALOME MEYER https://youtu.be/IygOCleU1Z4 SABC TV interviewed Salome Meyer from the Cancer Alliance on the problems around the cost of cancer medications, particularly Herceptin (trastuzumab), an important drug used for certain types of breast cancer.
Gauteng’s Oncology Crisis
https://www.youtube.com/watch?v=y6KaJ6q2-p4 It’s a story often repeated in South Africa’s neglected public healthcare system: old equipment, untrained staff, and a general lack of resources. In Gauteng, it’s a story that’s grown to reveal an unprecedented level of crisis. The province’s only...
Categories
SANCDA LETTER AND REPORT TO MINISTER OF HEALTH
Letter and Report to the Minister of Health, Dr Zweli Mkhize, from the South African Non-Communicable Diseases Alliance Please download and read the following two important documents: Letter to the new Minister of Health requesting urgent...
SUE JOHNSON SPEAKS ABOUT MULTIPLE MYELOMA AND LENALIDOMIDE
Sue Johnson and Lenalidomide Sue Johnson was diagnosed with breast cancer in 2008 and with Multiple Myeloma in 2014. While she was initially able to access a generic lenalidomide treatment from India on a Section 21 authorisation from the Medicines...
MOTIVATION FOR: PROMPT APPROVAL OF TRASTUZUMAB BIOSIMILARS TO PROMOTE COMPETITION IN THE MARKET
17 July 2019: Cancer Alliance submits a motivation to SAHPRA for the prompt approval of trastuzumab biosimilars to promote competition in the market. The Cancer Alliance of South Africa submits this memorandum in support of its request that SAHPRA...
LAUNCHING THE CAMPAIGN FOR ACCESS TO AFFORDABLE LENALIDOMIDE
Minister Mkhize must ensure access to cancer medicine that WHO now considers “essential” Johannesburg (9 July 2019) — It was announced today that lenalidomide, a lifesaving medicine to treat multiple myeloma, has been included on the latest edition...
SANCDA LETTER AND REPORT TO MINISTER OF HEALTH – JUNE 2019
Letter and Report to the Minister of Health, Dr Zweli Mkhize, from the South African Non-Communicable Diseases Alliance Please download and read the following two important documents: Letter to the new Minister of Health requesting urgent...
CANCER ALLIANCE PUBLISHES SECTION 4 OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: TREATMENT & PALLIATIVE CARE
Breast Cancer Control Policy 2017 25th February 2019 The Cancer Alliance today publishes the fourth and final part of its series on the Breast Cancer Control Policy with Section 4: Treatment & Palliative Care South Africa’s new Breast Cancer...
CANCER ALLIANCE CALLS FOR AFFORDABLE LENALIDOMIDE
Cancer Alliance calls for access to affordable lenalidomide for public and private sector patients in South Africa EMBARGOED UNTIL FRIDAY FEBRUARY 15 Many cancer patients in South Africa do not have access to affordable cancer medicines – many of...
CANCER ALLIANCE PUBLISHES SECTION 3 OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: ACCESS TO CARE
Breast Cancer Control Policy 2017 14th December 2018 The Cancer Alliance today publishes the third part of its series on the Breast Cancer Control Policy with Section 3: Access to Care. South Africa’s new Breast Cancer Control Policy is a vital...
WHAT IS UNIVERSAL HEALTH COVERAGE?
Universal health coverage (UHC) ensures all people, everywhere, can access the quality health services they need without suffering financial hardship. It is a fundamentally political goal rooted in the human right to health. It is also one of the...
OPEN LETTER TO THE SOUTH AFRICAN HEALTH PRODUCTS REGULATORY AUTHORITY (SAHPRA) ON ACCESS TO AFFORDABLE TRASTUZUMAB TREATMENT FOR WOMEN DIAGNOSED WITH HER2+
11 December 2018 Prof Helen Rees Chairperson: SAHPRA Dear Professor Rees and officials at SAHPRA, This letter could have been composed by ANY of the women in South Africa, diagnosed with HER2+ Breast Cancer who have been denied access to lifesaving...
CANCER ALLIANCE PUBLISHES SECTION 2 OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: AWARENESS AND PREVENTION
Breast Cancer Control Policy 2017 26th November 2018 The Cancer Alliance today continues its series on the Breast Cancer Control Policy with Section 2: Awareness and Prevention. South Africa’s new Breast Cancer Control Policy is a vital document...
CANCER ALLIANCE PUBLISHES THE FIRST SECTION OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: THE NEW POLICY
Breast Cancer Prevention and Control Policy 2017 The Cancer Alliance today publishes the first in a new series on the Breast Cancer Prevention and Control Policy 2017. South Africa’s new Breast Cancer Prevention and Control Policy is a vital...